European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 6 , Pages 646-652 , December 2008

Long-Term Cardiac Outcome in High-Risk Patients Undergoing Elective Endovascular or Open Infrarenal Abdominal Aortic Aneurysm Repair

  • O. Schouten

      Affiliations

    • Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • T.M. Lever

      Affiliations

    • Department of Vascular Surgery, Utrecht University Medical Center, Utrecht, The Netherlands
  • ,
  • G.M.J.M. Welten

      Affiliations

    • Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • T.A. Winkel

      Affiliations

    • Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • L.F.C. Dols

      Affiliations

    • Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • J.J. Bax

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
  • ,
  • R.T. van Domburg

      Affiliations

    • Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
  • ,
  • H.J.M. Verhagen

      Affiliations

    • Department of Vascular Surgery, Erasmus MC, Rotterdam, The Netherlands
    • Department of Vascular Surgery, Utrecht University Medical Center, Utrecht, The Netherlands
  • ,
  • D. Poldermans

      Affiliations

    • Department of Anesthesiology, Erasmus MC, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Vascular Surgery, Room H 921, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Tel.: +31104639222; fax: +31104634957.

Received 8 July 2008 ,Accepted 11 September 2008.

References 

  1. Blankensteijn JD, de Jong SE, Prinssen M, van der Ham AC, Buth J, van Sterkenburg SM, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005;352(23):2398–2405
  2. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364(9437):843–848
  3. Lederle FA. Abdominal aortic aneurysm–open versus endovascular repair. N Engl J Med. 2004;351(16):1677–1679
  4. Kertai MD, Boersma E, Bax JJ, Heijenbrok-Kal MH, Hunink MG, L'Talien GJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003;89(11):1327–1334
  5. Schouten O, Dunkelgrun M, Feringa HH, Kok NF, Vidakovic R, Bax JJ, et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2007;33(5):544–549
  6. Poldermans D, Fioretti PM, Forster T, Thomson IR, Boersma E, el-Said EM, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation. 1993;87(5):1506–1512
  7. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–969
  8. Back MR, Leo F, Cuthbertson D, Johnson BL, Shamesmd ML, Bandyk DF. Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg. 2004;40(4):752–760
  9. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199(2):223–233
  10. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA. 2001;285(14):1865–1873
  11. Welten GM, Schouten O, Hoeks SE, Chonchol M, Vidakovic R, van Domburg RT, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008;51(16):1588–1596
  12. Schouten O, Bax JJ, Dunkelgrun M, Feringa HH, van Urk H, Poldermans D. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg. 2006;44(2):419–424
  13. Kertai MD, Boersma E, Westerhout CM, Klein J, Van Urk H, Bax JJ, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2004;28(4):343–352
  14. Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leao P, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39(5):967–975[discussion 975–976]
  15. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med. 2004;116(2):96–103
  16. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl. 1):S1–S75
  17. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med. 1999;341(24):1789–1794
  18. Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LL, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J. 2001;22(15):1353–1358
  19. Kertai MD, Boersma E, Bax JJ, Thomson IR, Cramer MJ, van de Ven LL, et al. Optimizing long-term cardiac management after major vascular surgery: role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery. Arch Intern Med. 2003;163(18):2230–2235
  20. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–1847
  21. Fleisher LA, Poldermans D. Perioperative beta blockade: where do we go from here?. Lancet. 2008;371(9627):1813–1814
  22. Poldermans D, Bax JJ, Schouten O, Neskovic AN, Paelinck B, Rocci G, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol. 2006;48(5):964–969
  23. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet. 2005;365(9478):2187–2192
  24. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet. 2005;365(9478):2179–2186

PII: S1078-5884(08)00489-9

doi: 10.1016/j.ejvs.2008.09.008

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 6 , Pages 646-652 , December 2008